Oncology drugs for orphan indications: how are HTA processes evolving for this specific drug category?

Adkins EM, Nicholson L, Floyd D, Ratcliffe M, Chevrou-Severac H

ClinicoEconomics and Outcomes Research 2017, 9:327-342

Published Date: 10 June 2017